Boris Kerzner

Long-term safety and efficacy of a once-daily niacin/lovastatin formulation for patients with dyslipidemia**A complete list of participants in the Research Group and Publication Committee appears in the Appendix.

Moti L. Kashyap, Mark E. McGovern, Kathleen Berra et al. · The American Journal of Cardiology · 2002 · 234 citations

Pharmacy, Pharmacology, Pharmacotherapy +14

Efficacy and safety of ezetimibe coadministered with lovastatin in primary hypercholesterolemia

Boris Kerzner, John Corbelli, Stephan C. Sharp et al. · The American Journal of Cardiology · 2003 · 217 citations

Pharmacy, Pharmacology, Pharmacotherapy +12

MBX-8025, A Novel Peroxisome Proliferator Receptor-δ Agonist: Lipid and Other Metabolic Effects in Dyslipidemic Overweight Patients Treated with and without Atorvastatin

Harold Bays, Sherwyn Schwartz, Thomas Littlejohn et al. · The Journal of Clinical Endocrinology & Metabolism · 2011 · 148 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Adverse drug reactions—a matter of opinion

Fred E. Karch, Carol L. Smith, Boris Kerzner et al. · Clinical Pharmacology & Therapeutics · 1976 · 140 citations

Pharmacy, Pharmacology, Clinical Pharmacology +15

Efficacy and safety of ezetimibe coadministered with statins: randomised, placebo-controlled, blinded experience in 2382 patients with primary hypercholesterolemia

Michael H. Davidson, Christie M. Ballantyne, Boris Kerzner et al. · International Journal of Clinical Practice · 2004 · 134 citations

Pharmacy, Pharmacology, Pharmacotherapy +16